Does LAMIVUDINE Cause Hepatitis b reactivation? 308 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 308 reports of Hepatitis b reactivation have been filed in association with LAMIVUDINE (Lamivudine and Zidovudine). This represents 1.9% of all adverse event reports for LAMIVUDINE.
308
Reports of Hepatitis b reactivation with LAMIVUDINE
1.9%
of all LAMIVUDINE reports
50
Deaths
39
Hospitalizations
How Dangerous Is Hepatitis b reactivation From LAMIVUDINE?
Of the 308 reports, 50 (16.2%) resulted in death, 39 (12.7%) required hospitalization, and 15 (4.9%) were considered life-threatening.
Is Hepatitis b reactivation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LAMIVUDINE. However, 308 reports have been filed with the FAERS database.
What Other Side Effects Does LAMIVUDINE Cause?
Foetal exposure during pregnancy (1,905)
Virologic failure (1,894)
Drug resistance (1,889)
Pathogen resistance (1,733)
Viral mutation identified (1,631)
Treatment failure (933)
Exposure during pregnancy (846)
Drug interaction (744)
Drug ineffective (726)
Immune reconstitution inflammatory syndrome (625)
What Other Drugs Cause Hepatitis b reactivation?
RITUXIMAB (914)
CYCLOPHOSPHAMIDE (801)
DOXORUBICIN (684)
VINCRISTINE (641)
PREDNISONE (583)
PREDNISOLONE (465)
METHOTREXATE (305)
DEXAMETHASONE (293)
ETOPOSIDE (213)
TENOFOVIR DISOPROXIL (162)
Which LAMIVUDINE Alternatives Have Lower Hepatitis b reactivation Risk?
LAMIVUDINE vs LAMIVUDINE\NEVIRAPINE\ZIDOVUDINE
LAMIVUDINE vs LAMIVUDINE\TENOFOVIR
LAMIVUDINE vs LAMIVUDINE\TENOFOVIR DISOPROXIL
LAMIVUDINE vs LAMIVUDINE\ZIDOVUDINE
LAMIVUDINE vs LAMOTRIGINE